Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy Y Xiao, J Chen, H Zhou, X Zeng, Z Ruan, Z Pu, X Jiang, A Matsui, L Zhu, ... Nature communications 13 (1), 758, 2022 | 130 | 2022 |
Exosomes as drug carriers in anti-cancer therapy L Chen, L Wang, L Zhu, Z Xu, Y Liu, Z Li, J Zhou, F Luo Frontiers in Cell and Developmental Biology 10, 728616, 2022 | 66 | 2022 |
MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway LI Li, J Zhao, S Huang, Y Wang, L Zhu, Y Cao, J Xiong, J Deng Gene 641, 240-247, 2018 | 59 | 2018 |
Emerging role of immunotherapy for colorectal cancer with liver metastasis X Yu, L Zhu, J Liu, M Xie, J Chen, J Li OncoTargets and therapy, 11645-11658, 2020 | 34 | 2020 |
Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges L Zhu, X Yu, L Wang, J Liu, Z Qu, H Zhang, L Li, J Chen, Q Zhou Oncogenesis 10 (7), 47, 2021 | 33 | 2021 |
Sophoridine inhibits lung cancer cell growth and enhances cisplatin sensitivity through activation of the p53 and Hippo signaling pathways L Zhu, S Huang, J Li, J Chen, Y Yao, L Li, H Guo, X Xiang, J Deng, ... Gene 742, 144556, 2020 | 31 | 2020 |
The promising role of miR-296 in human cancer L Zhu, H Deng, J Hu, S Huang, J Xiong, J Deng Pathology-Research and Practice 214 (12), 1915-1922, 2018 | 29 | 2018 |
The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers L Zhu, J Liu, J Chen, Q Zhou Journal of hematology & oncology 14, 1-19, 2021 | 28 | 2021 |
A comprehensive understanding of choroidal metastasis from lung cancer Z Qu, J Liu, L Zhu, Q Zhou OncoTargets and therapy, 4451-4465, 2021 | 19 | 2021 |
Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer Z Lingling, L Jiewei, W Li, Y Danli, Z Jie, L Wen, P Dan, P Lei, Z Qinghua Pathology-Research and Practice 216 (4), 152852, 2020 | 19 | 2020 |
Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients S Huang, L Zhu, Y Cao, L Li, Y Xie, J Deng, J Xiong Oncotarget 8 (46), 80303, 2017 | 18 | 2017 |
Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis L Zhu, X Yu, T Cao, H Deng, X Tang, Q Lin, Q Zhou Acta Pharmaceutica Sinica B 13 (6), 2464-2482, 2023 | 16 | 2023 |
A spike protein S2 antibody efficiently neutralizes the Omicron variant J Hu, X Chen, X Lu, L Wu, L Yin, L Zhu, H Liang, F Xu, Q Zhou Cellular & molecular immunology 19 (5), 644-646, 2022 | 16 | 2022 |
Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: a systematic review and meta-analysis L Zhu, G Ma, J Liu, Y Deng, Q Wu, W Chen, Q Zhou Medicine 98 (16), e15069, 2019 | 12 | 2019 |
Updated Interpretation of the NCCN Clinical Practice Guidelines (Version 3. 2023) for Non-small Cell Lung Cancer. ZHU Lingling, W Ting, WU Juan, Z Xiaoqian, WU Qiang, D Hanyu, ... Chinese Journal of Lung Cancer 26 (6), 2023 | 9 | 2023 |
Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies X Yu, L Zhu, T Wang, J Chen Frontiers in Immunology 14, 1037945, 2023 | 8 | 2023 |
Tumor vessel normalization and immunotherapy in gastric cancer X Yu, S He, J Shen, Q Huang, P Yang, L Huang, D Pu, L Wang, L Li, J Liu, ... Therapeutic Advances in Medical Oncology 14, 17588359221110176, 2022 | 8 | 2022 |
Case report: anlotinib reverses nivolumab resistance in advanced primary pulmonary lymphoepithelioma-like carcinoma with FGFR3 gene amplification Y Liu, L Long, J Liu, L Zhu, F Luo Frontiers in oncology 11, 749682, 2021 | 7 | 2021 |
Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications X Zhai, Y Lin, L Zhu, Y Wang, J Zhang, J Liu, L Li, X Lu Cytokine & growth factor reviews 75, 101-109, 2024 | 6 | 2024 |
Robotic versus laparoscopic gastrectomy for gastric cancer in patients with obesity: systematic review and meta-analysis X Yu, L Zhu, Y Zhang, Q Feng Frontiers in Oncology 13, 1158804, 2023 | 6 | 2023 |